Hospital Liability Due to Wrong Blood Transfusion or Blood Product Administration

What is a wrong blood transfusion or blood product administration?

Wrong blood transfusion or wrong blood product administration is when a patient is harmed because they receive a blood product of a different blood type, incompatible, mislabeled, intended for the wrong patient, improperly tested, stored under compromised conditions, or not medically necessary, instead of the blood or blood component they need. This error can occur with erythrocyte suspension, platelet suspension, fresh frozen plasma, cryoprecipitate, whole blood, or other blood components.

Blood transfusion is not simply a matter of administering an IV drip. The transfusion process is a multi-stage medical procedure encompassing blood group determination, donor-recipient compatibility, cross-matching, proper preparation, storage, and transportation of the blood product, patient identification, physician order, nursing administration, monitoring during the transfusion, and emergency intervention if a reaction occurs.

The Regulation on Blood and Blood Products covers all public institutions, individuals, and private legal entities engaged in activities related to blood and blood components; the purpose of the Regulation is to regulate the establishment, equipment/personnel standards, quality assurance programs, and operating principles of transfusion centers, blood donation centers, and regional blood centers.

Therefore, in cases of incorrect blood transfusions, responsibility cannot be placed solely on the nurse administering the blood or the physician ordering it. The blood bank, transfusion center, laboratory, ward nurse, operating room team, intensive care team, physician, hospital management, and record-keeping system are all considered together. This is because incorrect blood transfusions often result not from the carelessness of a single person, but from multiple breaks in the patient safety chain.

In what ways does a wrong blood transfusion occur?

One of the most severe examples of incorrect blood transfusions is the administration of ABO-incompatible blood. Incompatibility between the patient's blood type and the transfused blood product can lead to acute hemolytic transfusion reactions, renal failure, disseminated intravascular coagulation, shock, and death. Therefore, ABO compatibility is one of the most fundamental aspects of transfusion safety.

The second major error is administering blood products to the wrong patient. For example, the names of two patients in the same ward may have been mixed up, the patient's wristband may not have been checked, the information on the blood bag may not have been compared with the patient's file, or the blood product may have been delivered to the wrong bed. Such errors usually indicate a deficiency in the identity verification system.

The third error is blood bag or sample mix-up. The sample taken for blood group determination may belong to another patient. The sample label may have been printed incorrectly in the laboratory. Cross-matching may have been performed with a sample from a different patient. In this case, even if the blood bag technically appears "suitable," it may not actually be suitable for the patient.

The fourth error is the deterioration of storage and transportation conditions. Blood and blood components must be stored under specific temperature and time conditions. The blood product may have been kept at an inappropriate temperature, left unused for a long time after being put to use, return conditions may not have been followed, or it may have passed its expiration date.

The fifth mistake is the delayed detection of a transfusion reaction. Even if the blood is correctly selected, the patient may develop fever, chills, back pain, shortness of breath, low blood pressure, dark urine, itching, rash, or signs of shock. Continuing the blood transfusion or failing to notify the doctor despite the appearance of these symptoms may lead to hospital liability.

Are all transfusion reactions a hospital error?

No. Not every transfusion reaction automatically means a hospital error. Blood and blood products are life-saving when medically necessary; however, some patients may develop fever, allergic reactions, delayed hemolytic reactions, or other complications despite proper procedures.

However, not every negative outcome is accurately categorized as a "complication." For a reaction to be considered a complication, the blood must have been given to the correct patient, as the correct product, after appropriate testing, under correct storage conditions, on the order of a physician, with patient identity verified, and with necessary follow-up.

If a patient has been given the wrong blood type, if the blood bag belongs to another patient, if the samples have been mixed up, if cross-matching has not been performed, if the blood product has been stored under inappropriate conditions, or if the transfusion has not been stopped despite the appearance of reaction signs, this cannot be explained away as a simple complication.

The Blood and Blood Products Regulation defines a "serious adverse event" as an event related to the collection, testing, processing, storage, or distribution of blood or blood components that may result in death, life-threatening complications, permanent disability, incapacity for work, or prolonged hospital stay in a patient following a transfusion. A "serious adverse effect" refers to an effect in a donor or patient that may cause similar severe consequences in connection with a transfusion.

Hospital and Physician Responsibility in Blood Transfusions

Blood transfusion is a procedure that must be performed under the responsibility and supervision of a physician. The Blood and Blood Products Regulation clearly stipulates that the collection of blood, blood components, and products from donors and their transfusion to recipients must be carried out under the responsibility and supervision of a physician. Furthermore, the collection, testing, processing, storage, preparation for use, distribution, and monitoring of feedback on transfusion practices related to blood and blood components are the responsibility of the relevant service unit.

This regulation shows that the blood transfusion process is not solely a nursing procedure. The physician must assess the medical necessity of the blood transfusion, determine which product to administer and in what quantity, consider the patient's risks, and plan the course of action to be taken in case of a reaction.

Before administering the transfusion, nurses and the ward staff should check the patient's identity, the information on the blood bag, blood group compatibility, product type, expiration date, request form, and patient file. After the transfusion, the patient's vital signs should be monitored; if symptoms such as fever, chills, shortness of breath, low blood pressure, back pain, or altered consciousness occur, the transfusion should be stopped immediately and the physician should be notified.

Hospital management is also responsible for establishing a secure blood transfusion system. The barcode system, patient wristbands, double staff verification, electronic ordering system, laboratory verification, blood bank records, hemovigilance reporting, and staff training are all part of the hospital's organizational responsibility.

Identity Verification and Patient Confusion

One of the most important reasons for incorrect blood transfusions is the failure to properly verify patient identity. Before administering a blood product, the patient's full name, Turkish Republic identity number, protocol number, date of birth, blood type, product type, and bag number must be checked. If the patient is unconscious, the patient's wristband, file, and electronic system should be compared.

Identity verification is not simply "asking the patient their name." Patients, especially in intensive care units, operating rooms, emergency rooms, delivery rooms, and those who are unconscious, may not be able to verify their own identity. In such cases, systemic security measures become even more crucial.

For example, the hospital's records and security system should be reviewed in cases such as two patients with the same name, bed changes, lack of patient wristbands, blood bags being left waiting in the ward, blood products being given to a different patient, or laboratory samples being incorrectly labeled.

The Blood and Blood Products Regulation stipulates that blood and blood products must be labeled in a way that ensures traceability at all stages; the label must include information such as the name of the component, service unit, ABO/Rh group, collection and expiration dates, and storage temperature. The service unit must also establish a system to track blood and blood products from collection to transfusion.

Cross-Comparison and Laboratory Errors

Before a blood transfusion, the patient's blood group, antibody status, and compatibility tests must be performed. Cross-matching is especially vital for products such as erythrocyte suspensions. Incorrect or incomplete cross-matching can result in the patient receiving incompatible blood.

Laboratory errors can occur in the following ways: The sample may have been taken from the wrong patient. The sample label may have been printed incorrectly. The blood group may have been determined incorrectly. The process may have been performed without checking the previous blood group record. The test result may have been entered incorrectly into the electronic system. The blood bank may have prepared blood products for a different patient.

In cases of such errors, not only laboratory personnel but also the service personnel who collected the sample, the physician who ordered it, the blood bank managers, and the hospital quality system are evaluated together. This is because transfusion safety operates in a chain-like manner, from the moment the sample is taken until the blood product is administered to the patient.

The regulation lists ABO and Rh D blood group testing among the basic laboratory tests to be performed on donors; it stipulates that the tests must be validated and that the algorithms and application methods must be carried out in accordance with the guidelines. This approach shows that the security of testing and records in blood products cannot be left to chance.

Storage and Transportation Conditions of Blood Products

Blood and blood components are subject to specific storage and transportation conditions. Storage temperature varies depending on the type of product. Storage conditions differ for erythrocyte suspension, platelets, plasma, and other components. Products stored at the wrong temperature or not used within the appropriate time frame can harm the patient.

The regulation stipulates that the storage and distribution of blood and blood components shall be carried out according to the guidelines; and that the integrity and storage temperature of blood and blood components shall be maintained during storage, packaging, and distribution. It also states that blood and blood components cannot be returned to the inventory until their compliance with quality requirements and procedures has been established.

Therefore, if a blood product has been left unattended for a long time after being released for service, has been kept in an unsuitable environment, has been returned to the blood bank, or if its storage temperature has not been recorded, the product's safety becomes questionable. In such cases, the blood product's release time, the person who received it, the transfusion start time, the return record, refrigerator temperature records, and product disposal records should be examined.

Transfusion Reaction and Emergency Response

A patient may develop a reaction during or after a blood transfusion. These may include acute hemolytic reactions, febrile reactions, allergic reactions, anaphylaxis, TRALI (Trail-Alzheimer's Syndrome), TACO (Tail-Alzheimer's Syndrome), infection, delayed hemolytic reactions, or other complications. While some of these reactions are mild, others can be life-threatening.

Monitoring the patient during a transfusion is essential. The first few minutes are particularly critical. If fever, chills, back or lower back pain, chest pain, shortness of breath, low blood pressure, pulse changes, darkening of urine color, rash, or altered consciousness occur, the blood transfusion should be stopped, the intravenous line should be kept open, the physician should be informed, the blood bag and set should be preserved, necessary blood and urine tests should be performed, and the event should be documented.

The regulation mandates the keeping of records and reporting to the Ministry of serious adverse effects and events observed before, during, or after transfusions that may be related to the quality and safety of blood and blood components. This reporting obligation demonstrates that blood transfusion errors are not merely an in-hospital matter; they are part of the national hemovigilance system.

Informed Consent for Blood Transfusions

Before a blood transfusion, the patient should be informed as much as possible. The patient should be told why they are receiving blood, which blood product will be used, if there are alternatives, the benefits and risks of the transfusion, the possibility of a reaction, and the consequences of refusing the transfusion.

The Patient Rights Regulation stipulates that patient consent is required for medical interventions; if the patient is a minor or has limited legal capacity, permission must be obtained from their guardian or legal representative; however, consent may not be required in cases where the patient lacks the capacity to express themselves or in an urgent life-threatening situation.

In emergency situations such as bleeding, trauma, surgery, postpartum bleeding, intensive care, or life-threatening anemia, obtaining patient consent may not be possible. However, if there is no emergency or the patient is conscious, blood transfusion should not be treated as a routine procedure, and the patient must be informed. The consent and information process should be conducted with particular care, especially for patients who refuse blood transfusions for religious or personal reasons.

Wrong Blood Transfusion at a Private Hospital

If a blood transfusion error occurs in a private hospital, private medical center, private surgical center, or private healthcare facility, private law liability arises. The private hospital may be held responsible for errors made by physicians, nurses, blood bank, laboratory, operating room, intensive care unit, and hospital organization.

A private hospital cannot easily escape responsibility by saying, "the nurse administered it incorrectly" or "it was a laboratory error." Because the patient receives safe blood transfusion services within the hospital's organizational structure. The hospital must establish the right patient, the right product, the right time, the right dose, the right route, and the right record-keeping system.

Private hospital cases also involve a contractual relationship between the patient and the healthcare institution. Therefore, in addition to treatment costs, intensive care expenses, permanent disability, incapacity for work, and moral damages due to incorrect blood transfusions, the refund of fees charged by the private hospital, additional treatment costs, and consumer law aspects are also evaluated on a case-by-case basis.

Wrong Blood Transfusion at State Hospital

If a blood transfusion error occurs in a state hospital, city hospital, training and research hospital, or public university hospital, the legal recourse often falls under administrative law. Healthcare services provided in state hospitals are public services. If this service is poorly performed, delayed, or not performed at all, the administration is considered to have committed a service defect.

According to Article 13 of the Administrative Procedure Law No. 2577, individuals whose rights have been violated by administrative actions must apply to the relevant administration for the fulfillment of their rights within one year from the date they learned of the action, and in any case within five years from the date of the action, before filing a lawsuit. A lawsuit may be filed if the application is rejected or if no response is given within thirty days.

Therefore, before filing a lawsuit regarding an alleged blood transfusion error at a public hospital, a detailed application should be submitted to the relevant administration. This application should clearly state the date of the incident, the type of blood product administered, when the reaction occurred, the nature of the harm, the connection to the death (if any), the requested compensation for material and moral damages, and any required records.

What are the potential harms of a wrong blood transfusion?

Incorrect blood transfusions can have very serious medical consequences. Transmission of ABO-incompatible blood can cause an acute hemolytic reaction. This can result in fever, chills, back pain, low blood pressure, dark urine, kidney failure, shock, disseminated clotting disorders, the need for intensive care, and death.

Rh incompatibility or antibody incompatibilities can sometimes lead to delayed hemolytic reactions. Incorrect blood products or improper storage conditions can cause infection, sepsis, pulmonary edema, respiratory failure, or organ damage.

Incorrect administration of platelets, plasma, or other blood components can also cause harm. For example, unnecessary plasma administration can lead to fluid overload, incorrect platelet administration can cause adverse reactions, and high-volume transfusions, due to improper monitoring, can result in heart failure or pulmonary edema.

These harms have serious consequences, not only medically but also legally. The patient may require intensive care, lose kidney function, need dialysis, experience organ failure, become permanently disabled, or die.

What types of compensation can be claimed?

Patients who suffer harm due to incorrect blood transfusions or faulty blood product administration may claim compensation for both material and non-material damages. Material compensation may include treatment costs, intensive care expenses, medication costs, dialysis costs, rehabilitation costs, physical therapy costs, medical equipment costs, caregiver costs, private hospital costs, travel and accommodation costs, temporary disability, permanent disability, loss of earnings, and damage to economic future.

For example, if kidney failure develops due to a wrong blood transfusion, the patient's dialysis costs, lifetime follow-up expenses due to organ damage, loss of working capacity, and care needs should be calculated. If the patient has been in intensive care for a long period, all treatment and care expenses during this period should also be considered as damages.

Compensation for emotional distress is claimed due to the patient's suffering, fear of death, intensive care period, organ loss, permanent disability, mental breakdown, violation of bodily integrity, and decreased quality of life. If the patient has passed away, their relatives may claim compensation for loss of support, funeral expenses, and compensation for emotional distress.

Can a criminal investigation be opened?

If a wrong blood transfusion results in serious injury, organ loss, permanent disability, or death, a criminal investigation may be initiated. Depending on the nature of the incident, the crimes of negligent injury or negligent homicide will be discussed. Article 89 of the Turkish Penal Code regulates negligent injury; as of 2025, the basic penalty range in the current text is imprisonment from four months to two years or a judicial fine.

In a criminal investigation, the following questions are examined: Was the physician's order correct? Was a blood group test performed? Was the sample taken from the correct patient? Was the blood bag prepared correctly? Was the patient's identity checked? Did the staff administering the blood perform the necessary checks? Was the procedure stopped when signs of a reaction appeared? Was the incident recorded?

Criminal investigations and civil lawsuits are different. Criminal investigations examine the criminal responsibility of individuals. Civil lawsuits, on the other hand, aim to compensate the patient or their relatives for material and moral damages. However, forensic medical reports or expert opinions obtained in criminal cases can be very important evidence in civil lawsuits.

How can a wrong blood transfusion be proven?

In cases of incorrect blood transfusions, the proof process relies entirely on records. Therefore, patients or their relatives should request all medical and transfusion records without delay. The regulation stipulates that service units must record their activities in written or electronic form and retain them for 15 years; and that donor basic test results must be stored electronically for 30 years. Furthermore, to ensure full traceability of blood and blood products, information must be stored for a period of no less than 30 years.

The required documents are: blood transfusion request form, patient blood group result, cross-matching result, blood bag label, product number, product dispatch record, receiving personnel record, transfusion start and end times, nurse observation form, vital sign monitoring chart, reaction form, laboratory results, blood culture, urinalysis, kidney function tests, intensive care unit records, discharge summary, death certificate, and autopsy report (if available).

In addition, blood bank records should be examined to determine which donor the blood product came from, what tests it underwent, at what temperature it was stored, on what date it was released for service, and what happened to it if it was not transfused. The regulation stipulates that a procedure must be prepared to determine whether each released unit was transfused to the recipient and, if not, what happened to it.

The Importance of Expert Reports

In cases of incorrect blood transfusions, the expert report determines the outcome of the case. The expert panel should include specialists from the fields of transfusion medicine, hematology, intensive care, anesthesia, nephrology, infectious diseases, emergency medicine, forensic medicine, and nursing practices.

The expert must answer the following questions: Was the blood transfusion medically necessary for the patient? Which product should have been administered? Was the patient's blood type correctly determined? Was cross-matching performed? Was the blood bag suitable for the patient? Was there any sample mix-up? Was patient identity verified? Was the blood product stored under appropriate conditions? Were signs of a reaction noticed in time? Was there a causal link between the harm and the transfusion error?

Incomplete expert reports must be challenged. Simply stating "it could be a transfusion reaction" or "it's a complication" is insufficient. The report must concretely examine blood bag number, blood group, cross-match result, product dispensing time, transfusion initiation time, reaction findings, and laboratory changes.

What should the patient or their relatives do?

If there is suspicion of a wrong blood transfusion, the first thing to do is to request all medical records in writing. The Patient Rights Regulation stipulates that patients can review and obtain copies of their health-related files and records directly or through their representative.

The second step is to establish a chronology of events. When was the blood requested? When was the blood type determined? When was the blood bag delivered to the ward? When did the transfusion begin? When was the first sign of a reaction observed? When was the blood transfusion stopped? When did the doctor arrive? When was the patient admitted to the intensive care unit? This chronology forms the basis for expert examination.

The third step is to correctly distinguish between private and public hospitals. In private hospitals, private law, consumer law, and malpractice liability come into play; in public hospitals, administrative appeals and full judicial proceedings become relevant.

The fourth step is to identify the damages. If the patient is alive, this includes medical expenses, intensive care, disability, organ damage, caregiver needs, and emotional distress; if the patient has passed away, it includes loss of support, funeral expenses, and claims for compensation for emotional distress by relatives.

Conclusion: Wrong Blood Transfusion Leads to Serious Hospital Liability

Wrong blood transfusions or incorrect blood product administration are among the most serious patient safety breaches in healthcare. This is because blood transfusion is a multi-stage process that must be recorded, controlled, and conducted under physician supervision. Blood grouping, cross-matching, labeling, storage, patient identification, nurse monitoring, reaction management, and hemovigilance reporting are integral parts of this process.

Not every transfusion reaction is a hospital error. However, hospital, physician, nurse, laboratory, and blood bank liability may arise if the wrong blood type is given, blood is administered to the wrong patient, a sample or bag is mixed up, cross-matching is incorrect, blood product is improperly stored, patient identity is not verified, or intervention is delayed despite signs of a reaction.

In such cases, a successful legal process is possible not only with the claim of "wrong blood transfusion," but also by concretely demonstrating the causal link between the harm and the blood bag number, blood group records, cross-match results, transfusion form, nurse observation records, reaction reports, and laboratory values. Patients or their relatives who have suffered harm due to a wrong blood transfusion should immediately gather the records, determine the correct legal course of action according to whether it was a private or public hospital, and prepare the file in a way that is suitable for expert examination.